Cargando…

Risk factors for indicators of opioid-related harms amongst people living with chronic non-cancer pain: Findings from a 5-year prospective cohort study

BACKGROUND: The literature suggests patient characteristics and higher opioid doses and long-term duration are associated with problematic opioid behaviours but no one study has examined the role of all these factors simultaneously in a long-term prospective cohort study. METHODS: Five-year, communi...

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell, Gabrielle, Noghrehchi, Firouzeh, Nielsen, Suzanne, Clare, Phillip, Bruno, Raimondo, Lintzeris, Nicholas, Cohen, Milton, Blyth, Fiona, Hall, Wayne, Larance, Briony, Hungerford, Phillip, Dobbins, Timothy, Farrell, Michael, Degenhardt, Louisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700907/
https://www.ncbi.nlm.nih.gov/pubmed/33294810
http://dx.doi.org/10.1016/j.eclinm.2020.100592
_version_ 1783616380611854336
author Campbell, Gabrielle
Noghrehchi, Firouzeh
Nielsen, Suzanne
Clare, Phillip
Bruno, Raimondo
Lintzeris, Nicholas
Cohen, Milton
Blyth, Fiona
Hall, Wayne
Larance, Briony
Hungerford, Phillip
Dobbins, Timothy
Farrell, Michael
Degenhardt, Louisa
author_facet Campbell, Gabrielle
Noghrehchi, Firouzeh
Nielsen, Suzanne
Clare, Phillip
Bruno, Raimondo
Lintzeris, Nicholas
Cohen, Milton
Blyth, Fiona
Hall, Wayne
Larance, Briony
Hungerford, Phillip
Dobbins, Timothy
Farrell, Michael
Degenhardt, Louisa
author_sort Campbell, Gabrielle
collection PubMed
description BACKGROUND: The literature suggests patient characteristics and higher opioid doses and long-term duration are associated with problematic opioid behaviours but no one study has examined the role of all these factors simultaneously in a long-term prospective cohort study. METHODS: Five-year, community-based, prospective cohort of people prescribed opioids for chronic non-cancer pain (CNCP). Logistic mixed effect models with multiple imputation were used to address missing data. Oral morphine equivalent (OME) mg per day was categorised as: 0 mg OME/day, 1–49 mg OME/day (reference), 50–89 mg OME/day, 90–199 mg OME/day and 200mg+ OME/day. Patient risk factors included: age, gender, substance use, mental health history and pain-related factors. Main outcomes included: Prescribed Opioids Difficulties Scale (PODS), Opioid-Related Behaviours In Treatment (ORBIT) scale, and ICD-10 opioid dependence. Multiple confounders for problematic opioid behaviours were assessed. FINDINGS: Of 1,514 participants 44.4% were male (95%CI 41.9–46.9) and their mean age was 58 years (IQR 48–67). Participants had a mean duration of pain of 10 years (IQR 4.5–20.0) and had been taking strong opioids for a median of four years (IQR 1.0–10.0). At baseline, median OME/day was 73 (IQR 35–148). At 5-years, 85% were still taking strong opioids. PODS moderate-high scores reduced from 59.9% (95%CI 58.8–61.0) at baseline to 51.5% (95%CI 50.0–53.0) at 5-years. Around 9% met criteria for ICD-10 opioid dependence at each wave. In adjusted mixed effect models, the risk factors most consistently associated with problematic opioid use were: younger age, substance dependence, mental health histories and higher opioid doses. INTERPRETATION: Both patient risk factors and opioid dose are associated with problematic opioid use behaviours.
format Online
Article
Text
id pubmed-7700907
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-77009072020-12-07 Risk factors for indicators of opioid-related harms amongst people living with chronic non-cancer pain: Findings from a 5-year prospective cohort study Campbell, Gabrielle Noghrehchi, Firouzeh Nielsen, Suzanne Clare, Phillip Bruno, Raimondo Lintzeris, Nicholas Cohen, Milton Blyth, Fiona Hall, Wayne Larance, Briony Hungerford, Phillip Dobbins, Timothy Farrell, Michael Degenhardt, Louisa EClinicalMedicine Research Paper BACKGROUND: The literature suggests patient characteristics and higher opioid doses and long-term duration are associated with problematic opioid behaviours but no one study has examined the role of all these factors simultaneously in a long-term prospective cohort study. METHODS: Five-year, community-based, prospective cohort of people prescribed opioids for chronic non-cancer pain (CNCP). Logistic mixed effect models with multiple imputation were used to address missing data. Oral morphine equivalent (OME) mg per day was categorised as: 0 mg OME/day, 1–49 mg OME/day (reference), 50–89 mg OME/day, 90–199 mg OME/day and 200mg+ OME/day. Patient risk factors included: age, gender, substance use, mental health history and pain-related factors. Main outcomes included: Prescribed Opioids Difficulties Scale (PODS), Opioid-Related Behaviours In Treatment (ORBIT) scale, and ICD-10 opioid dependence. Multiple confounders for problematic opioid behaviours were assessed. FINDINGS: Of 1,514 participants 44.4% were male (95%CI 41.9–46.9) and their mean age was 58 years (IQR 48–67). Participants had a mean duration of pain of 10 years (IQR 4.5–20.0) and had been taking strong opioids for a median of four years (IQR 1.0–10.0). At baseline, median OME/day was 73 (IQR 35–148). At 5-years, 85% were still taking strong opioids. PODS moderate-high scores reduced from 59.9% (95%CI 58.8–61.0) at baseline to 51.5% (95%CI 50.0–53.0) at 5-years. Around 9% met criteria for ICD-10 opioid dependence at each wave. In adjusted mixed effect models, the risk factors most consistently associated with problematic opioid use were: younger age, substance dependence, mental health histories and higher opioid doses. INTERPRETATION: Both patient risk factors and opioid dose are associated with problematic opioid use behaviours. Elsevier 2020-10-16 /pmc/articles/PMC7700907/ /pubmed/33294810 http://dx.doi.org/10.1016/j.eclinm.2020.100592 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Paper
Campbell, Gabrielle
Noghrehchi, Firouzeh
Nielsen, Suzanne
Clare, Phillip
Bruno, Raimondo
Lintzeris, Nicholas
Cohen, Milton
Blyth, Fiona
Hall, Wayne
Larance, Briony
Hungerford, Phillip
Dobbins, Timothy
Farrell, Michael
Degenhardt, Louisa
Risk factors for indicators of opioid-related harms amongst people living with chronic non-cancer pain: Findings from a 5-year prospective cohort study
title Risk factors for indicators of opioid-related harms amongst people living with chronic non-cancer pain: Findings from a 5-year prospective cohort study
title_full Risk factors for indicators of opioid-related harms amongst people living with chronic non-cancer pain: Findings from a 5-year prospective cohort study
title_fullStr Risk factors for indicators of opioid-related harms amongst people living with chronic non-cancer pain: Findings from a 5-year prospective cohort study
title_full_unstemmed Risk factors for indicators of opioid-related harms amongst people living with chronic non-cancer pain: Findings from a 5-year prospective cohort study
title_short Risk factors for indicators of opioid-related harms amongst people living with chronic non-cancer pain: Findings from a 5-year prospective cohort study
title_sort risk factors for indicators of opioid-related harms amongst people living with chronic non-cancer pain: findings from a 5-year prospective cohort study
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700907/
https://www.ncbi.nlm.nih.gov/pubmed/33294810
http://dx.doi.org/10.1016/j.eclinm.2020.100592
work_keys_str_mv AT campbellgabrielle riskfactorsforindicatorsofopioidrelatedharmsamongstpeoplelivingwithchronicnoncancerpainfindingsfroma5yearprospectivecohortstudy
AT noghrehchifirouzeh riskfactorsforindicatorsofopioidrelatedharmsamongstpeoplelivingwithchronicnoncancerpainfindingsfroma5yearprospectivecohortstudy
AT nielsensuzanne riskfactorsforindicatorsofopioidrelatedharmsamongstpeoplelivingwithchronicnoncancerpainfindingsfroma5yearprospectivecohortstudy
AT clarephillip riskfactorsforindicatorsofopioidrelatedharmsamongstpeoplelivingwithchronicnoncancerpainfindingsfroma5yearprospectivecohortstudy
AT brunoraimondo riskfactorsforindicatorsofopioidrelatedharmsamongstpeoplelivingwithchronicnoncancerpainfindingsfroma5yearprospectivecohortstudy
AT lintzerisnicholas riskfactorsforindicatorsofopioidrelatedharmsamongstpeoplelivingwithchronicnoncancerpainfindingsfroma5yearprospectivecohortstudy
AT cohenmilton riskfactorsforindicatorsofopioidrelatedharmsamongstpeoplelivingwithchronicnoncancerpainfindingsfroma5yearprospectivecohortstudy
AT blythfiona riskfactorsforindicatorsofopioidrelatedharmsamongstpeoplelivingwithchronicnoncancerpainfindingsfroma5yearprospectivecohortstudy
AT hallwayne riskfactorsforindicatorsofopioidrelatedharmsamongstpeoplelivingwithchronicnoncancerpainfindingsfroma5yearprospectivecohortstudy
AT larancebriony riskfactorsforindicatorsofopioidrelatedharmsamongstpeoplelivingwithchronicnoncancerpainfindingsfroma5yearprospectivecohortstudy
AT hungerfordphillip riskfactorsforindicatorsofopioidrelatedharmsamongstpeoplelivingwithchronicnoncancerpainfindingsfroma5yearprospectivecohortstudy
AT dobbinstimothy riskfactorsforindicatorsofopioidrelatedharmsamongstpeoplelivingwithchronicnoncancerpainfindingsfroma5yearprospectivecohortstudy
AT farrellmichael riskfactorsforindicatorsofopioidrelatedharmsamongstpeoplelivingwithchronicnoncancerpainfindingsfroma5yearprospectivecohortstudy
AT degenhardtlouisa riskfactorsforindicatorsofopioidrelatedharmsamongstpeoplelivingwithchronicnoncancerpainfindingsfroma5yearprospectivecohortstudy